DDRE-10. IMMUNE PROFILES ASSOCIATE WITH OUTCOMES IN HLA-A*02:01(+), H3.3K27M(+) PATIENTS WITH DIFFUSE MIDLINE GLIOMAS TREATED WITH H3.3K27M PEPTIDE VACCINE COMBINED WITH POLY-ICLC: A PNOC REPORT

BACKGROUND: Patients with diffuse midline gliomas (DMG), including diffuse intrinsic pontine glioma (DIPG), have dismal outcomes. We previously described the H3.3K27M mutation as a shared neoantigen in HLA-A*02.01(+) H3.3K27M(+) DMGs. Within the Pacific Pediatric Neuro-Oncology Consortium, we assess...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Mueller, Sabine, Taitt, Jared M, Villanueva-Meyer, Javier, Bonner, Erin R, Nejo, Takahide, Lulla, Rishi R, Goldman, Stewart, Banerjee, Anurhada, Chi, Susan, Whipple, Nicholas S, Crawford, John R, Gauvain, Karen, Nazemi, Kellie, Watchmaker, Payal, Almeida, Neil D, Okada, Kaori, Salazar, Andres, Gilbert, Ryan, Nazarian, Javad, Molinaro, Annette, Butterfield, Lisa H, Prados, Michael, Okada, Hideho
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Drug Discovery, Drug Resistance
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651114/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.255
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak